Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.7731
-0.0069 (-0.88%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7300
-0.0431 (-5.57%)
After-hours: Sep 18, 2026, 7:55 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $15.06 million as of September 18, 2026. Its market cap has increased by 26.54% in one year.
Market Cap
15.06M
Enterprise Value
8.09M
1-Year Change
26.54%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $15.06M, a decrease of -78.70%. That is a compound annual growth rate of -13.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 15.10M | 125.37% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 15.37M |
| Dyadic International | 14.67M |
| Enlivex | 14.18M |
| GT Biopharma | 14.09M |
| Pluri | 14.07M |
| Niki BioSolutions | 14.02M |
| Quoin Pharmaceuticals | 13.86M |
| Adial Pharmaceuticals | 13.76M |